In an elderly woman with intestinal tuberculosis and a prior history of pulmonary tuberculosis, should steroids be added to her anti‑tubercular regimen, and what dosage and precautions are recommended?

Steroid Use in Intestinal Tuberculosis

In an elderly woman with intestinal tuberculosis, adjunctive corticosteroids should be considered and can reduce morbidity from complications like intestinal obstruction and adhesions, but must only be used alongside adequate anti-tubercular therapy. 1

Evidence for Steroid Use in Intestinal TB

The strongest evidence comes from a retrospective study specifically examining peritoneal/intestinal tuberculosis 1. This study demonstrated that patients receiving corticosteroids plus anti-TB therapy had:

• Significantly fewer complications: Only 1/9 steroid-treated patients had recurrent abdominal pain versus 19/26 controls
• No emergency department visits for abdominal pain (versus 7 visits in controls)
• No intestinal obstructions requiring laparotomy (versus 5 controls needing surgery for adhesions)
• No deaths (versus 3 deaths in controls)

Recommended Approach

When to Use Steroids

Corticosteroids are indicated in intestinal TB when:

• Significant systemic symptoms (fever, severe abdominal pain)
• Risk of intestinal obstruction or extensive adhesions
• Large inflammatory mass or extensive disease

Dosing Regimen

Based on general TB corticosteroid protocols 2, 3:

• Prednisone 40-60 mg orally daily for 4-6 weeks
• Followed by tapering doses over subsequent weeks
• Total duration typically 6-8 weeks

Critical Precautions in Elderly Patients

Must address before starting steroids:

1. Ensure adequate anti-TB coverage is established first - Never give steroids without concurrent anti-tubercular therapy 4
2. Screen for latent TB reactivation risk - Though already active disease, ensure no additional sites 5
3. Osteoporosis prophylaxis - Especially critical in elderly women; initiate calcium, vitamin D, and consider bisphosphonates 5
4. Monitor for steroid complications more common in elderly 5:
   • Hyperglycemia/diabetes
   • Psychosis/confusion
   • Myopathy (can worsen functional status)
   • Infection risk

Drug Interactions Specific to This Case

Rifampin reduces corticosteroid effectiveness 6:

• Rifampin induces hepatic metabolism of corticosteroids
• Double the corticosteroid dose if patient is on rifampin-containing regimen 6
• Monitor clinical response closely

Monitoring During Treatment

• Weekly clinical assessment for first 2-4 weeks
• Assess for abdominal pain, obstruction symptoms
• Monitor blood glucose (especially in elderly)
• Watch for steroid side effects (confusion, weakness)
• Ensure anti-TB drug adherence continues

Important Caveats

Do not prolong corticosteroid therapy beyond 6-8 weeks - No evidence for maintenance benefit and increases adverse effects 7. The goal is to prevent acute complications during initial TB treatment, not long-term suppression.

Avoid delaying definitive anti-TB therapy - Corticosteroids are purely adjunctive; the anti-tubercular regimen is the definitive treatment 7.

Risk-benefit in elderly: While steroids reduce mechanical complications (obstruction, adhesions), elderly patients face higher risks of steroid toxicity 5. The decision favors steroid use when complications would require surgery or cause significant morbidity, which is more dangerous in elderly patients than a time-limited steroid course.